Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. CRISPR made up ...

This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...

The convergence of genomics, systems biology, and artificial intelligence is transforming the landscape of drug discovery. Modern genomic technologies now ...

Detailed price information for Ark Innovation ETF (ARKK-A) from The Globe and Mail including charting and trades.

CorriXR Therapeutics announced new peer-reviewed findings showing that its CRISPR-based gene-editing approach can resensitize squamous cell lung carcinoma (LUSC) tumors to standard chemotherapy, ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

Key breakthrough for the return of the dodo: viable cells have been obtained and genetically modified birds have been prepared.

To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...

CRISPR-based gene editing has revolutionized modern biology, but these tools are unable to access the DNA that resides inside ...